Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Children’s Hospital Boston researchers regenerate zebrafish heart muscle

13.12.2002


Work has implications for repairing human heart muscle after heart attacks



Experiments on zebrafish provide important clues that could eventually lead to the ability to regenerate damaged human heart muscle, say researchers from the Howard Hughes Medical Institute at Children’s Hospital Boston. Reporting in the Dec. 13 issue of Science, a team led by HHMI investigator Mark T. Keating, MD, senior associate, department of Cardiology, showed for the first time that zebrafish can regenerate heart muscle within two months after a severe injury. The team also identified a possible genetic and molecular model for regeneration in zebrafish that could help direct further research in humans. The findings, while still in an early stage, might someday benefit millions of people who suffer heart attacks or experience other forms of cardiac injury.

The zebrafish is the subject of active study because of its ability to regenerate spinal cord, retina, and fins. This finding points to the study of zebrafish heart regeneration as a means to understand and reduce cardiac injury in humans. When a human heart is injured, it cannot "grow back" the damaged muscle, which is instead replaced by scar tissue. Too much scarring can impair the heart’s ability to pump and can lead to life-threatening arrhythmias. Keating and his colleagues believe that zebrafish, unlike humans, have especially vigorous development of new heart-muscle cells, or cardiomyocytes. This proliferation of cells regenerates the heart muscle with little or no scarring.


"We think that there’s a balance between scar formation and regeneration -- if you regenerate, you don’t scar, but if you can’t regenerate, you scar," Keating said. "If you inhibit cell proliferation in the zebrafish, the heart doesn’t regenerate and instead scars, like in humans. The implication, which isn’t proven, but is quite exciting, is that by enhancing human cardiomyocyte proliferation after heart injury, one may be able to enhance cardiac regeneration and reduce cardiac scarring."

In the experiments, Keating and co-authors Kenneth D. Poss and Lindsay G. Wilson, also of HHMI and Children’s Hospital Boston, injured the hearts of adult zebrafish by surgically removing 20 percent of the muscle from the heart’s lower chamber, or ventricle. They then returned the animals to water (most survived and resumed swimming) and examined their hearts at regular intervals. They compared their observations with those of a control group of zebrafish that had their hearts removed and returned to their bodies uninjured.

Within a week, the zebrafish with heart injuries were as active and swam as well as the zebrafish whose hearts were uninjured. Within two months, most injured ventricles had regained their size and shape and appeared to be contracting normally. Digitally aided measurements of the ventricles’ surface area showed complete recovery of heart muscle. Cardiomyocytes rapidly increased in number at the edge of the wound, first forming a layer to restore the ventricle wall, and then expanding this new layer of muscle.

Using techniques of cell biology, Keating’s team also showed that zebrafish with a genetic mutation affecting the enzyme mitotic checkpoint kinase (Mps1) no longer had rapid heart-cell formation and lost their ability to regenerate heart muscle. Instead, they had muscle scarring, as humans do. However, Keating emphasized this mutation is not necessarily the mechanism that inhibits cell proliferation in humans.

The next research steps will be to further investigate what genes are required for cardiomyocyte proliferation and heart regeneration in zebrafish, and to seek their counterparts in humans. Two major questions must then be answered. "Can you enhance cardiomyocyte proliferation in humans? That’s not known," Keating said. "And, if you enhance proliferation, will it induce cardiac regeneration?"

Many amphibians, such as newts, lizards, and salamanders, are also able to regenerate organs and tissues, whereas mammals, including humans, are not. But the zebrafish is an especially valuable model for studying the molecular mechanisms that trigger regeneration, because its genome shares many characteristics with the human genome. The small tropical fish also reproduces rapidly, facilitating genetic studies over multiple generations. A scientific push to sequence the zebrafish genome is under way at Children’s Hospital Boston and elsewhere.

"The field of regeneration has been of interest for thousands of years, but it hasn’t really entered the mainstream of molecular biology," said Keating. "The reason, in my opinion, is that the tools haven’t been there. We decided to create the field of zebrafish regeneration genetics."


Children’s Hospital Boston is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults for over 100 years. More than 500 scientists, including seven members of the National Academy of Sciences, nine members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children’s research community. Founded in 1869 as a 20-bed hospital for children, Children’s Hospital Boston today is a 300-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. It is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital visit: www.childrenshospital.org.

This research was funded by the Helen Hay Whitney Foundation and grants from the National Heart, Lung, and Blood Institute.


Elizabeth Andrews | EurekAlert!
Further information:
http://www.childrenshospital.org/

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>